← Back

$ Value

$0

Shares

668

Price

$0

Filed

Jun 4

Insider

Name

Farkas Charles

Title

CIK

0001615538

Roles

Director

Transaction Details

Transaction Date

2025-06-02

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

668

Footnotes

The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service. | Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.

Filing Info

Accession No.

0001127602-25-016762

Form Type

4

Issuer CIK

0000816956

Farkas Charles's History

Date Ticker Type Value
2025-09-12 CNMD $59K
2025-09-12 CNMD $48K
2025-06-03 CNMD M $0
2025-06-03 CNMD M $0
2025-06-02 CNMD A $0
2025-06-02 CNMD A $0
2025-05-29 CNMD M $56K
2025-05-29 CNMD F $56K
2025-05-29 CNMD M $0
2025-05-05 CNMD $228K

Other Insiders at CNMD (90d)

Insider Bought Sold Last
Beyer Pat
President & CEO
2026-04-01